NASDAQ : CLOV
Clover Health Investments, Corp. — Key statistics
Healthcare · Healthcare Plans · United States
Last price 4.58 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.43B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.29B |
| Enterprise Value | 2.09B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 435.44M |
| Shares Outstanding | 531.16M |
| Shares Change (YoY) | +3.75% |
| Shares Change (QoQ) | +4.46% |
| Owned by Insiders (%) | 21.64% |
| Owned by Institutions (%) | 28.39% |
| Float | 412.70M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 57.24 |
| PS Ratio | 0.93 |
| Forward PS | 0.71 |
| PB Ratio | 6.27 |
| P/TBV Ratio | 6.16 |
| P/FCF Ratio | 30.99 |
| P/OCF Ratio | 29.86 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 28.31 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.50 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -5.10% |
| Return on Assets (ROA) | -1.77% |
| Return on Invested Capital (ROIC) | -3.19% |
| Return on Capital Employed (ROCE) | -4.62% |
| Weighted Average Cost of Capital (WACC) | 17.80% |
| Revenue Per Employee | $3.42M |
| Profits Per Employee | -$25,362 |
| Employee Count | 724 |
| Asset Turnover | 3.82 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.46 |
| 52-Week Price Change | +22.81% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 41.69 |
| Average Volume (20 Days) | 4,175,132 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 25.95M |
| Short Previous Month | 22.90M |
| Short % of Shares Out | 4.89% |
| Short % of Float | 6.29% |
| Short Ratio (days to cover) | 5.73 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.48B |
| Gross Profit | 459.13M |
| Operating Income | -18.36M |
| Pretax Income | -18.36M |
| Net Income | -18.36M |
| EBITDA | -17.96M |
| EBIT | -18.36M |
| Loss Per Share | -$0.04 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 243.10M |
| Total Debt | n/a |
| Net Cash | 198.84M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 376.26M |
| Book Value Per Share | 0.71 |
| Working Capital | 162.12M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 77.03M |
| Capital Expenditures | -2.83M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 74.21M |
| FCF Per Share | $0.14 |
Margins
| Measure | Value |
|---|
| Gross Margin | 18.54% |
| Operating Margin | -0.74% |
| Pretax Margin | -0.74% |
| Profit Margin | -0.74% |
| EBITDA Margin | -0.73% |
| EBIT Margin | -0.74% |
| FCF Margin | 3.00% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.75% |
| Shareholder Yield | -3.75% |
| Earnings Yield | -0.95% |
| FCF Yield | 3.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.50 |
| Price Target Difference | 27.61% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 27.01% |
| EPS Growth Forecast (3Y) | 75.27% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |